Related references
Note: Only part of the references are listed.Renal fibroblasts and myofibroblasts in chronic kidney disease
Frank Strutz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Experimental strategies to reverse chronic renal disease
M Zeisberg et al.
BLOOD PURIFICATION (2004)
Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction
JW Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Evidence that fibroblasts derive from epithelium during tissue fibrosis
M Iwano et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Smad7 inhibits fibrotic effect of TGF-β on renal tubular epithelial cells by blocking Smad2 activation
JH Li et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Renal fibrosis:: an update
M Zeisberg et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2001)
Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy
S Mizuno et al.
KIDNEY INTERNATIONAL (2001)
TGF-β1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2)
F Strutz et al.
KIDNEY INTERNATIONAL (2001)
Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF
RS Lo et al.
EMBO JOURNAL (2001)
How cells read TGF-β signals
J Massagué
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2000)
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways
YH Liu et al.
KIDNEY INTERNATIONAL (2000)
Transforming growth factor-β1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction
Y Isaka et al.
KIDNEY INTERNATIONAL (2000)
The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease
S Klahr et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
